Full-length transcript amplification and sequencing as universal method to test mRNA integrity and biallelic expression in mismatch repair genes
Authors:
Open Access
- 22 July 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 27 (12) , 1808-1820
Abstract
In pathogenicity assessment, RNA-based analyses are important for the correct classification of variants, and require gene-specific cut-offs for allelic representation and alternative/aberrant splicing. Beside this, the diagnostic yield of RNA-based techniques capable to detect aberrant splicing or allelic loss due to intronic/regulatory variants has to be elaborated. We established a cDNA analysis for full-length transcripts (FLT) of the four DNA mismatch repair (MMR) genes to investigate the splicing pattern and transcript integrity with active/inhibited nonsense-mediated mRNA-decay (NMD). Validation was based on results from normal controls, samples with premature termination codons (PTC), samples with splice-site defects (SSD), and samples with pathogenic putative missense variants. The method was applied to patients with variants of uncertain significance (VUS) or unexplained immunohistochemical MMR deficiency. We categorized the allelic representation into biallelic (50 ± 10%) or allelic loss (≤10%), and >10% and 10% and 30% of VUS. Our method allows a standardized, systematic cDNA analysis of the MMR FLTs to assess the pathogenicity mechanism of VUS on RNA level, which will gain relevance for precision medicine and gene therapy. Diagnostic accuracy will be enhanced by detecting MMR defects in hitherto unsolved patients. The data generated will help to calibrate a high-throughput NGS-based mRNA-analysis and optimize prediction programs.Keywords
Funding Information
- Wilhelm Sander-Stiftung (2012.081.1, 2012.081.1)
- Deutsche Krebshilfe (111222, 111222)
This publication has 57 references indexed in Scilit:
- Comprehensive functional assessment ofMLH1variants of unknown significanceHuman Mutation, 2012
- Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variantsHuman Mutation, 2012
- Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndromeJournal of Medical Genetics, 2011
- Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance studyEuropean Journal of Human Genetics, 2009
- Prediction and assessment of splicing alterations: implications for clinical testingHuman Mutation, 2008
- Mutations in the MutSα interaction interface of MLH1 can abolish DNA mismatch repairNucleic Acids Research, 2006
- A ‘Nonsense’ Mutation Leads to Aberrant Splicing of hMLH1 in a German Hereditary Non-polyposis Colorectal Cancer FamilyFamilial Cancer, 2006
- Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humansProceedings of the National Academy of Sciences, 2002
- Enhanced Detection of Deleterious and Other Germline Mutations of hMSH2 and hMLH1 in Japanese Hereditary Nonpolyposis Colorectal Cancer KindredsBiochemical and Biophysical Research Communications, 2000
- Transcripts with splicings of exons 15 and 16 of the hMLH1 gene in normal lymphocytes: implications in RNA-based mutation screening of hereditary non-polyposis colorectal cancerEuropean Journal of Cancer, 1998